MP14-19 MAGNETIC CLEARANCE OF KIDNEY STONE FRAGMENTS: INITIAL IN VITRO EXPERIENCE

Abstract

You have accessJournal of UrologyCME1 May 2022MP14-19 MAGNETIC CLEARANCE OF KIDNEY STONE FRAGMENTS: INITIAL IN VITRO EXPERIENCE Tianjia Jessie Ge, Timothy Chang, Kathy Mach, Shan Wang, Kunj Sheth, Simon Conti, and Joseph Liao Tianjia Jessie GeTianjia Jessie Ge More articles by this author , Timothy ChangTimothy Chang More articles by this author , Kathy MachKathy Mach More articles by this author , Shan WangShan Wang More articles by this author , Kunj ShethKunj Sheth More articles by this author , Simon ContiSimon Conti More articles by this author , and Joseph LiaoJoseph Liao More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002543.19AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Surgical management of stone disease aims for complete clearance. Residual stone fragments are associated with more complications, yet only 60-75% of ureteroscopic treatments achieve complete stone-free status. While residual fragments <2 mm in size are commonly deemed insignificant, up to 30% patients with “clinically insignificant fragments” experience stone-related complications. We propose a system to improve stone-free rates and surgical efficiency, in which fragments are rendered superparamagnetic and retrieved en masse with a magnetic guidewire. METHODS: Human kidney stone fragments obtained from lithotripsy (calcium phosphate (CaPO4), calcium oxalate monohydrate (CaOxM), uric acid, and struvite) were separated by size. Fragments (10-15 mg by dry weight) were rehydrated with normal saline and incubated with superparamagnetic iron oxide particles (range 7 nm to 4.5 µm diameter) possessing carboxylic acid surface chemistry for 3 minutes at 37C. A magnetic guidewire was fabricated from individual magnets within a plastic sheath (0.75 mm total diameter) and captured magnetically labeled fragments along its length in vitro. The fragments were dried and weighed to determine the capture efficiency. The speed of fragment retrieval was compared between the magnetic system and a conventional basket. RESULTS: The magnetic system cleared small fragments (<1 mm) up to twenty times faster than a standard basket in our in vitro experiments. The 7 nm nanoparticle, ferumoxytol, is FDA-approved for the treatment of iron deficiency anemia, and performed satisfactorily in capturing small calcium phosphate fragments. Larger 1 micron particles performed more consistently across different stone compositions. Capture efficiency decreases with increasing stone fragment size, owing to larger gravitational forces counteracting the magnetic attraction. CONCLUSIONS: Iron oxide particles with carboxylic acid surface chemistries, including an FDA-approved nanoparticle, bind to a variety of calcium-based kidney stones. This approach can facilitate the efficient magnetic retrieval of small stone fragments which are difficult to basket, and lead to improved stone-free rates. Further optimization of particle chemistry and magnetic forces will allow for capture of larger fragments and clinical translation. Source of Funding: Stanford Coulter Translational Grant, NIH R21 DK131776 © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 207Issue Supplement 5May 2022Page: e240 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Tianjia Jessie Ge More articles by this author Timothy Chang More articles by this author Kathy Mach More articles by this author Shan Wang More articles by this author Kunj Sheth More articles by this author Simon Conti More articles by this author Joseph Liao More articles by this author Expand All Advertisement PDF DownloadLoading ...